- Home
- NOM vs DYAI Comparison
NOM vs DYAI Comparison
Compare NOM & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOM | DYAI |
|---|---|---|
| Founded | 1993 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 29.9M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NOM | DYAI |
|---|---|---|
| Price | $11.42 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 6.9K | ★ 34.1K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.52 | $0.71 |
| 52 Week High | $10.48 | $1.73 |
Technical Indicators
Market Signals| Indicator | NOM | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 38.19 |
| Support Level | $10.99 | $0.87 |
| Resistance Level | $11.85 | $0.92 |
| Average True Range (ATR) | 0.31 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 43.00 | 22.94 |
Price Performance
Historical ComparisonAbout NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.